Rabea Voget

Bonn, NW 53121, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

From Inhibitor to Reporter: Nirmatrelvir-Derived Fluorogenic Substrates for the SARS-CoV-2 Main Protease.

From Inhibitor to Reporter: Nirmatrelvir-Derived Fluorogenic Substrates for the SARS-CoV-2 Main Protease.

Journal: ACS chemical biology

Published: June 16, 2026

Early Kinetic Characterization of SARS-CoV-2 Main Protease Inhibitors: A Review and Guidance for Biochemical Assessments.

Early Kinetic Characterization of SARS-CoV-2 Main Protease Inhibitors: A Review and Guidance for Biochemical Assessments.

Journal: Biochemistry

Published: March 29, 2026

Sequential Optimization Approach Toward an Azapeptide-Based SARS-CoV-2 Main Protease Inhibitor.

Sequential Optimization Approach Toward an Azapeptide-Based SARS-CoV-2 Main Protease Inhibitor.

Journal: Archiv der Pharmazie

Published: August 14, 2025

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.

Journal: Journal of medicinal chemistry

Published: July 17, 2025

Development and Characterization of the First Selective Class IIb Histone Deacetylase Degraders.

Development and Characterization of the First Selective Class IIb Histone Deacetylase Degraders.

Journal: Journal of medicinal chemistry

Published: June 18, 2025

Salamandamide Lipodipeptides Are Biosynthetic Intermediate Shunt Products of the Nonamodular Nonribosomal Peptide Assembly Lines of the Viscosin Family.

Salamandamide Lipodipeptides Are Biosynthetic Intermediate Shunt Products of the Nonamodular Nonribosomal Peptide Assembly Lines of the Viscosin Family.

Journal: Journal of natural products

Published: April 15, 2025

Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs.

Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs.

Journal: Journal of medicinal chemistry

Published: May 16, 2024

Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives.

Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives.

Journal: Bioorganic & medicinal chemistry letters

Published: March 19, 2024

Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity".

Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity".

Journal: ACS pharmacology & translational science

Published: February 27, 2024

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.

Journal: ACS pharmacology & translational science

Published: November 10, 2023

Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs.

Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs.

Journal: Journal of medicinal chemistry

Published: October 30, 2023

Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics.

Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics.

Journal: Acta pharmaceutica Sinica. B

Published: September 21, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026